Yes Rowdy................same situation with Resmed and may others........RMD was recommended as a buy/strong buy by every broker report I've seen on it...........all the way from $12 to $4.40 just recently. Just illustrates that most research houses should get a technical analyst who knows their stuff and that their methods (DCF etc........) often leave a lot to be desired.
Takes another hammering, page-4
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$293.70 |
Change
1.690(0.58%) |
Mkt cap ! $141.9B | |||
| Open | High | Low | Value | Volume |
| $293.55 | $294.28 | $292.12 | $189.1M | 644.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 956 | $293.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $293.70 | 763 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |